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inactivating A-type outward K ϩ current; B1/B2 receptor; adenosine 3Ј,5Ј-cyclic monophosphate/protein kinase A BRADYKININ (BK) IS AN ENDOGENOUS nonapeptide, which is generated by cleavage of the kininogen substrates by the kallikreins. It has been reported that BK acts on neuronal tissue as well as nonneuronal tissue to produce a number of effects including hypertension, arteriolar dilatation, increased vascular permeability, and pain (4, 31) . The actions of BK are mediated through the activation of specific receptors that are coupled to multiple signal transduction pathways (10, 35, 36) . In mammals, at least two receptors have been identified: the bradykinin B 1 and B 2 receptors. B 2 receptors are not only found on neurons but are also expressed by nonneuronal cells such as glial cells (44) and have been located on cultured astrocytes, oligodendrocytes, and microglia (9, 13, 35) . In Schwann cells (SCs) of dorsal root ganglia (DRG), BK induced the release of glutamate via activation of B 2 receptors (39).
In addition to being regarded as a mediator of inflammation and vasodepression, a number of studies have shown that BK can modulate membrane ion channels and membrane conductance. BK has been demonstrated to evoke a Ca 2ϩ -activated chloride current in nonneuronal cells isolated from neonatal rat DRG (6) . BK also stimulated T-and L-type Ca 2ϩ currents in heart cells via stimulation of B 2 receptors, inducing a positive chronotropic effect (5) . In vagal afferent neurons (nodose ganglion neurons), BK increased membrane conductance by activating Ca 2ϩ -activated ClϪ conductance while reducing membrane conductance by decreasing K ϩ conductance (37) . In addition, a recent study by Liu et al. (27) demonstrated that BK activated calcium-dependent K ϩ channels in cultured human airway smooth muscle cells via the release of inositol 1,4,5-trisphosphate-sensitive intracellular Ca 2ϩ stores. However, there have been only a few studies concerning the possible role of BK in modifying voltage-gated K ϩ channels. Schwann cells are responsible for myelination of nerve fibers in the peripheral nervous system. Schwann cells purified from mouse sciatic nerves are known to proliferate, exhibiting mostly a premyelinating phenotype (32) . The whole cell recording technique has revealed that all SCs exhibit prominent voltage-gated outward K ϩ currents, including inactivating Atype (I A ), delayed-rectifier (I K ), and inward-rectifier (I IR ) K ϩ channels, which constitute the main conductance found in SCs (38, 43) . Molecular and physiological studies have previously shown that I K channels may play an important role in SC proliferation and that they are modulated by Src (40) . Moreover, recent studies have begun to address the molecular identity of K ϩ channel ␣-subunits in SCs (38) . In the present study, we used the whole cell patch-clamp recording technique to examine the effects of BK on the outward K ϩ current, the BK receptors involved, and the relevant signaling pathway in SCs.
MATERIALS AND METHODS
Schwann cell culture. Isolated primary Schwann cell cultures were prepared from 4-day-old ICR mouse sciatic nerves according to Brockes et al. (2) . Isolated cells were then plated onto poly-L-lysinecoated (10 g/ml) 35-mm-diameter petri dishes (Costar, Corning, NY) at a density of 10 5 cells per dish. Cultured cells were incubated at 37°C with 5% CO 2 in Dulbecco's modified Eagle's medium/ Nutrient Mixture F-12 Ham (DMEM/Ham's F-12) supplemented with 10% fetal calf serum, insulin (5 g/ml), and 1% antibiotic-antimycotic solution. After culturing for 24 h, cytosine 1-␤-D-arabinofuranoside (5 M/l) was added to the culture medium to eliminate actively proliferating fibroblasts for 48 h. On day 4, cultured cells were washed and maintained in fresh medium to stimulate Schwann cell proliferation. Within 7 days, Schwann cell purity could reach above 90%, which was confirmed by their bright, narrow, bipolar morphology under Nomarski image and positive immunoreactivity for S-100. Cultured cells were expanded by passaging when confluent monolayers were obtained (every 7-10 days) and subcultured no more than five times. All experiments were carried out using Schwann cells from P3-P5 in culture.
Patch-clamp recordings. Whole cell currents of granule neurons were recorded using a patch-clamp technique. Before I A current recording, the culture medium was replaced with a bath solution containing (in mM) 120 NaCl, 5 KCl, 10 HEPES, 5 CaCl 2, 2 MgCl2, and 20 tetraethylammonium chloride (TEA) (pH adjusted to 7.4 using NaOH). Soft glass recording pipettes were filled with an internal solution containing (in mM): 11 K gluconate, 164 KCl, 10 HEPES, 1 CaCl 2, 2 MgCl2, and 11 EGTA (pH adjusted to 7.3 using KOH). The pipette resistance was 6 -7 M⍀ after filling with the internal solution. Bradykinin solutions were prepared extemporaneously, and gravity was ejected for 10 -20 s from MSC-200 Manual Solution Changer (Bio-Logic-Science Instruments). All recordings were performed at room temperature (23-25°C) .
Data acquisition and analysis. All currents were recorded using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA) operated in voltage-clamp mode. A Pentium computer was connected to the recording equipment with a Digidata 1300 analog-to-digital (A/D) interface. Current was digitally sampled at 100 s (10 kHz). The current signals were filtered by a 3-kHz, 3-pole Bessel filter. Currents were corrected online for leak and residual capacitance transients by a P/4 protocol. Data acquisition and analysis were performed with pClamp 8.01 software (Axon Instruments) and/or Origin6.1 (Microcal analysis software, Northampton, MA). Statistical analysis was performed using Student's t-test with nonpaired comparison or paired comparisons where it was relevant. Values are given as means Ϯ SE, with n as the number of cell tested. P Ͻ 0.05 was used to denote the statistical difference between groups. When multiple comparisons were made, data were analyzed by a one-way ANOVA test.
cAMP assay. cAMP levels were measured as previously described (3). Briefly, 1 ϫ 10 5 cells were plated in each 35-mm dish and grown to confluence. Cells were washed with 1 ml of media and preincubated at 37°C for 10 min in the presence of the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (2.5 mM) (Sigma). Cells were incubated an additional 3 min at 37°C with or without BK with varying concentrations of 100 nM, 1 M, and 5 M. The media were removed, and 0.5 ml of 0.1 M HCl with 0.8% Triton X-100 (Sigma) was added to the plates. After 30 min of incubation at room temperature, the lysate was removed from the plates and centrifuged for 2 min. The supernatant was collected and assayed for cAMP levels using a direct cAMP enzyme immunoassay kit (Assay Designs) according to the manufacturer's instructions. Protein concentrations in each sample were determined using a BCA Protein Assay Kit (Pierce). 
RESULTS
We investigated whether BK inhibited I A amplitude using a bath solution containing 20 mM TEA to eliminate I K currents. I A currents were evoked by 500-ms constant depolarizing pulses, ranging from Ϫ80 mV to 60 mV at 10-s intervals. Application of BK to the bath solution produced a clear reduction in I A current amplitude. The inhibitory effect of BK on I A was reversible, reached its maximum effect within 200 -250 s, and recovered to control levels after 1-2 min. Moreover, the BK-induced effect on I A was concentration dependent. The inhibition of I A produced by BK at 100 nM, 500 nM, and 1 M was 16.9 Ϯ 3.9% (n ϭ 6), 25.5 Ϯ 3.3% (n ϭ 5), and 29.6 Ϯ 1.5% (n ϭ 5), respectively (P Ͻ 0.05 using one-way ANOVA). When the concentration of BK was increased to 5 M, I A decreased to 46 Ϯ 3.9% (n ϭ 6) of the control. Fig. 1A illustrates a series of typical experiments in which BK was applied at different concentrations. Statistical analysis of the concentration-response data are summarized in Fig. 1B .
The effect of BK on the activation and inactivation of I A was studied using the appropriate voltage protocols. In the voltage activation protocol, membrane potential was held at Ϫ80 mV, and I A was evoked by a 500-ms depolarizing pulse from a first pulse potential of Ϫ50 mV to ϩ100 mV in 10-mV steps at 10-s intervals ( Fig. 2A) . When the depolarizing pulse was more positive than Ϫ10 mV, BK reduced the current amplitude throughout the activation voltage range (Fig. 2B) . When the peak current evoked from each command potential was normalized to the maximal current amplitude, we obtained the I A activation curve. As shown in Fig. 2C , the activation curve was shifted to the left by the application of BK. The current was half-activated at Ϫ10.6 Ϯ 1.9 mV and Ϫ24.1 Ϯ 4.0 mV in the absence and presence of 500 nM BK, respectively (n ϭ 5, P Ͻ 0.05 using Student's t-test), suggesting that BK treatment significantly modified the voltage dependence of steady-state activation of I A channels.
To study the effect of BK on steady-state inactivation of I A , currents were elicited using 1-s conditioning prepulses from Ϫ70 mV to various membrane potentials before a 400-ms test pulse of ϩ60 mV as show by Sobko et al.'s report (43) (Fig. 3,  A and B) . After normalizing each current peak to the maximal current amplitude obtained from the Ϫ70-mV prepulses as a function of the conditioning prepulse potential, we obtained an inactivation curve of I A and calculated the V h 50 (the voltage at which the current amplitude was half-inactivated; Fig. 3C ). We found that BK did not affect the steady-state inactivation curve. In four cells studied, the half-maximal inactivation voltage was Ϫ35.1 Ϯ 0.2 mV and Ϫ37.3 Ϯ 0.2 mV in the absence and presence of BK (500 nM), respectively (n ϭ 4, P Ͻ 0.05 using Student's t-test).
Because previous studies in SCs of the DRG revealed that BK induced the release of glutamate via activation of B 2 receptors (39), experiments were carried out to identify whether and which BK receptors might mediate the BKinduced augmentation of I A currents. We first investigated whether B 2 receptors might be involved in the BK effect on the I A current by using a specific antagonist of the B 2 receptor, B6029. As shown in Fig. 4A , 100 nM B6029 alone did not change the current; however, in the presence of 100 nM B6029, the BK-induced effect on I A current was blocked (Fig. 4A) . The 500 nM BK-induced effect on the I A current amplitude was 109 Ϯ 3.7% of the control (n ϭ 4, P Ͻ 0.05). In contrast, the B 1 receptor antagonist, B6929, did not abolish the BK-induced inhibitory effect on the I A current. In the presence of B6929, the inhibition of I A produced by 500 nM BK was 26.1 Ϯ 1.9% (n ϭ 4), not significantly different from the effect induced by BK alone (Fig. 4B) . The statistical analysis of these experiments is shown in Fig. 4C . BK receptors are coupled receptors known as the G proteincoupled receptors that mediate multiple signal transduction pathways (10, 36) . This possible pathway was tested in the BK-induced effect on I A currents by adding GTP-␥S (100 M) to the pipette solution. Internal infusion of GTP-␥S (100 M) resulted in the gradual suppression of I A amplitude after membrane rupture (Fig. 5A) . The amplitude declined significantly from 1,969.2 Ϯ 284.5 pA at the control level to 1,234.7 Ϯ 225.9 pA, a decrease of 34.9 Ϯ 8.6% (P Ͻ 0.05, n ϭ 6). Moreover, following the reduction in I A amplitude by internal application of GTP-␥S, BK induced average reductions in I A amplitude of 11.9 Ϯ 3.0% (n ϭ 6), which was significantly different from that induced by BK alone (P Ͻ 0.05). Since several G proteins could be involved in this process, we also investigated the role of G i / o and G s proteins using the G s inhibitor NF449, as well as NF023, which inhibits both G i and G o activation with similar potency (7) . As shown in inhibition of 5.9 Ϯ 1.2%. Intracellular loading with NF023 (10 M) also significantly increased I A amplitude from 1,416.8 Ϯ 312.9 pA to 1,762.1 Ϯ 423.5 pA after membrane rupture, an increase of 22.5 Ϯ 12.0% of the control (Fig. 5C , P Ͻ 0.05, n ϭ 5); however, BK decreased I A by 18.8 Ϯ 3.5% (Fig. 5C ), no significant difference was observed when compared with BK alone (P Ͻ 0.05, n ϭ 4). This result suggested that G s was required for I A reduction induced by BK.
It is well known that the G s subtype directly enhances cAMP synthesis by activating adenylyl cyclase. To address whether the cAMP/PKA pathway contributed to the inhibitory effect of BK on I A , the effect of BK was further investigated in the presence of an agonist of PKA. Perfusion of SCs with 1 M forskolin provoked a gradual decrease in I A amplitude from 2,504.2 Ϯ 319.2 pA to 1,584.3 Ϯ 326.4 pA, a reduction of 36.7 Ϯ 6.2%, similar with that induced by 500 nM BK. Moreover, in the presence of forskolin, BK only inhibited I A currents by 6.4 Ϯ 1.2% (Fig. 6, A and B) . A uniform perfusion of 10 M db-cAMP, a membrane-permeable cAMP analog, produced a significant reduction of 24.8 Ϯ 4.6% in I A currents and abolished the BK-induced inhibitory effect on I A (Fig. 6C) . In the presence of forskolin or cAMP, the BK-induced inhibitory effect on I A was 6.4 Ϯ 1.2% and 6.0 Ϯ 1.9%, respectively, with no significant differences compared with the control ( Fig. 6D , P Ͻ 0.05, n ϭ 8 and n ϭ 6). To determine the mechanism by which the PKA pathway was involved in the BK-induced effect on I A currents, H-89, a selective PKA antagonist, was used. After addition of H-89 into the patch pipette solution to inhibit PKA, the I A current was significantly increased to 143.3 Ϯ 7.1% of the control. Furthermore, H-89 significantly limited the effect of BK on the I A current to 125 Ϯ 9.9% (Fig. 7A) . In contrast, after the PKC pathway was activated by using PMA, the amplitude of the I A current was significantly increased after the establishment of the whole cell configuration and reached its maximum within 2-4 min. The percentage of the amplitude increased with intracellular PMA and was 154.4 Ϯ 15% of the control (n ϭ 4, P Ͻ 0.05 using Student's t-test).
The effects of BK on the intracellular level of cAMP were detected by using a direct cAMP enzyme immunoassay in SCs exposed to BK. The results shown in Fig. 8 indicate that a basic cAMP level (15.1 Ϯ 2.1 pmol, n ϭ 5) was detected in SCs before the addition of BK. When the cultures were incubated with 100 nM BK for 3 min or 10 min, the level of cAMP activity was significantly increased to 24.8 Ϯ 5.6 pmol and 33.8 Ϯ 7.5 pmol, respectively (P Ͻ 0.05, compared with the control group and each other, n ϭ 5). 
DISCUSSION
Bradykinin is an endogenous peptide and has diverse biological actions, but its effects on the voltage-gated K ϩ current have been poorly investigated. In this study, for the first time we showed that BK activated I A channel currents in SCs with the modulation of steady-state activation, via a G proteincoupled B 2 receptor, and was mediated by cAMP/PKA-dependent signal transduction.
Although a number of studies have demonstrated that BK can modulate membrane ion channels in the cardiovascular system and in kidneys (5, 45) , a direct observation in the voltage-gated K ϩ current had not been widely reported before this study, especially in the neuronal system. Our results demonstrated that BK not only decreased the I A amplitude, but also modified its gate character. The normalized activation and inactivation curves showed that the steady-state activation curve significantly left-shifted ϳ10 mV. In fact, I A is fully available for activation at potentials near the resting potential, and the presence of a "window current" suggests that I A could greatly increase resting K ϩ efflux, so that it may mediate proapoptotic K ϩ efflux in some cases (11, 23, 33) . Here, the left shift in the steady-state activation curve produced the resultant window current increasing toward the hyperpolarizing membrane potential, which may help to activate other types of K ϩ channels such as the I K channel and then increase K ϩ efflux.
In mammals, at least two subtypes of BK receptors have been identified: the bradykinin B 1 receptor and B 2 receptor (30). The kinin B 1 receptors are not normally expressed in healthy tissues, whereas the kinin B 2 receptors are constitutively expressed and are widely distributed throughout central and peripheral tissues in most organs, except the liver and spleen (28) . However, although most of the physiological actions of BK are believed to be mediated by stimulation of the B 2 receptors, the role of the B 1 receptor in the control of cardiovascular function, modulation of pain, and activation of the Na ϩ /Ca 2ϩ exchanger has been reported recently (18, 24) . In the present work, we showed that the selective B 1 receptor antagonist failed to eliminate the BK-induced inhibitory effect on I A currents. In contrast, the selective B 2 receptor antagonist significantly abolished the BK-induced inhibitory effect on I A currents. The results suggested that the B 2 receptor but not the B 1 receptor seemed to mediate the BK-induced inhibitory effect on I A . These results were consistent with the findings of Parpura et al. (39) obtained from SCs in the DRG, in which BK induced the release of glutamate via the B 2 receptor.
The BK receptor is known to be a G protein-coupled receptor and to transduce biological effects via multiple signal pathways (10, 36) . Using a COS-7 cell expression system, Liebmann (26) revealed that stimulation of the B 2 receptor led to mitogen-activated protein kinase signal transduction. In murine proximal tubule epithelial cells, a BK-induced rise in chloride current was mediated by G q protein-coupled B 2 receptors (45) . By using inhibitors of G␣ s , G␣ i , and G␣ o , we investigated the role of G␣ s and G␣ i / o proteins in this process. The results showed that the BK receptor and G␣ s proteins were associated in SCs because the BK-induced effect was fully mimicked by GTP-␥S and prevented by the G␣ s inhibitor. However, it was notable that both G s and G␣ i/o inhibitors provoked a gradual increase in I A amplitude. This increase in I A by inhibition of G␣ s indicated that basic or unknown causal G␣ s activity may be associated with the basic G protein activity, whereas the results in which inhibition of G␣ i/o produced augmentation of I A indicated that, in mouse SCs, G␣ i/o was mediated by inhibition of adenylyl cyclase, rather than activation of PKC, because our results revealed that stimulation of the PKC pathway by PMA increased I A amplitude. However, G␣ i/o may interact with other second messengers, such as Ca 2ϩ , PLC, and PLA 2 , as suggested in recent reports (25) .
Cyclic AMP is an important modulator of Schwann cell physiology in vitro (19, 20) . Furthermore, it is known that a number of the voltage-dependent K ϩ channels, including I A , I K , and Ca 2ϩ -activated K ϩ channels, are regulated by cAMP/ PKA or PKC pathways (1, 17, 29, 34 ), even though it is not after the establishment of the whole cell configuration, and the BK-induced inhibitory effect on the I A current was completely prevented by H-89, suggesting that the cAMP/PKA pathway mediated the BK-induced inhibitory effect on the I A current. Our findings are different from those of Xu et al. (46) , in which they revealed that activation of I A was positively regulated by PKA in neurofibromatosis type-1 gene (Nf1) null mouse SCs.
However, we note that the increase in I A was long-term mediated via neurofibromatosis type-1 gene (Nf1) null mutations leading to activation of PKA by an increase in the expression of functional channels, rather than by the phosphorylation of channel subunits and drive-altered channel activation or inactivation properties by short-term activation of the cAMP/PKA pathway, as in the present study and in a previous report by Gallego et al. (8) involving ␣ 1 -adrenoceptor that induced a reduction in the amplitude of the transient outward current (I to ) by activating the cAMP/PKA signaling cascade, which in turn led to I to channel phosphorylation (8) . Whether long-term treatment of SCs by BK induces the upregulated expression of the I A channel will require further investigation. Although previous investigations in human airway smooth muscle cells and astrocytes have revealed that the B 2 receptor mediated the activation of the PKC pathway (12, 14) , the PKC pathway may be excluded from the BK-induced inhibitory effect on I A current in SCs because our results demonstrated that stimulation of the PKC pathway by PMA produced a significant increase in I A currents, which was different from the BK-mediated inhibitory effect on I A currents.
In excitable cells such as neurons or myocardial cells, the functional roles of I A include influencing cell excitability, action-potential firing, controlling spike latency, and repetitive firing (41) . I A is also an excellent target for any modulatory mechanism influencing cell excitability and action potential firing (21, 41) . We showed previously that apoptosis of cerebellar granular neurons induced by low potassium and free serum was associated with increased I A (15) (16) (17) , suggesting an important function of I A channels. Although the precise function of I A in SCs is not known, its aberrant expression may have important implications for tumorigenesis in SCs, because voltage-gated K ϩ channel activity in glia is clearly linked to proliferation and differentiation (22, 42, 43, 46) . Therefore, the inhibitory effect on I A mediated by activation of the BK receptor might reveal an important significance in modulating SCs proliferation and differentiation and open a valuable new avenue for investigation, in terms of therapeutic and/or basic research applications of BK.
In summary, the present study provides evidence that B2 receptor stimulation couples the receptor to a G␣ s protein. This coupling to G␣ s is functional and activates the cAMP/ PKA signaling cascade, which leads to I A amplitude reduction in mouse SCs. This appears to be the first example, in a physiological preparation, in which BK receptors were linked to the cAMP/PKA pathway and to the modulation of the I A current. 
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